Clinical trial NCT05410717
Status: RecruitingPhase 1Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
- Record number
- NCT05410717
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 1
- Participants
- Target: 200
- Condition (as registered)
- Stage IV Ovarian Cancer, Testis Cancer, Refractory, Endometrial Cancer Recurrent, CAR NK
- Countries
- China
- Topic in the guide
- Cancer Treatment
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: June 1, 2022
- End of data collection for primary results: June 1, 2030 (expected)
- Trial completion: May 31, 2036 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Cancer Treatment: ongoing trials · Thinking of taking part? Which specialist to see